Sexual Dysfunction Male
Conditions
Brief summary
The purpose of this study was to investigate the effects of Lepidium meyenii (Maca) extract supplementation on male sexual funtion.
Detailed description
All participants performed anthropometric measurements, blood collection and questionnaire survey at 0-week. A random, double-blind design will be used to assign 60 participants into the experimental group (n = 30) or placebo group (n = 30). All participants consumed either 2.25 g Lepidium meyenii (Maca) extract twice per day for 12 weeks. The anthropometric measurements, blood samples, and questionnaire survey were collected again at 6-week, 12-week, 16-week, and 24-week. Data will be analyzed by two-way mixed design ANOVA.
Interventions
DIETARY_SUPPLEMENTMaca
2.25 g Lepidium meyenii (Maca) extract twice per day for 12 weeks
DIETARY_SUPPLEMENTPlacebo
Placebo
Sponsors
Taipei Medical University
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Masking description
A double-blind, matched-pair study design
Intervention model description
assign 60 participants into the experimental group (n = 30) or placebo group (n = 30)
Eligibility
Sex/Gender
MALE
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. evaluated as sexual dysfunction for more than three months by physician 2. international index of erectile function (IIEF) score is less than or equal to 21 3. erectile hardness score (EHS) score is less than or equal to 3 4. aged over 18 years old
Exclusion criteria
1. unable to cooperate with the course of the treatment 2. suffering from sexually transmitted diseases such as Syphilis, AIDS and HPVs 3. had Radical Prostatectomy (total removal of the prostate gland) 4. suffering from active tumors in the prostate or pelvic area 5. suffering from Hypogonadism 6. anatomical deformation of the penis 7. men with penile prosthesis 8. suffering from psychotic disorder (manic disorder, chronic depression, etc.) 9. suffering from neurological diseases (multiple sclerosis, brain or spinal cord injuries, etc.) 10. using Permanent pacemaker 11. considered unsuitable to participate in this experiment according to the doctor 12. alcohol or drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IIEF-5 score | Baseline (before supplementation) |
| EHS score | Baseline (before supplementation) |
| level of PSA | Baseline (before supplementation) |
| Testosterone level | Baseline (before supplementation) |
| LH level | Baseline (before supplementation) |
| Level of FSH | Baseline (before supplementation) |
Countries
Taiwan
Contacts
Primary ContactMing Ta Yang, Doctorate
Outcome results
None listed